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Abstract
Background: Vaginal hysterectomy is often used to correct uterovaginal prolapse, however,
there is little information regarding outcomes after surgery in routine clinical practice. The
objective of this study was to investigate complications, sexual activity, urinary symptoms, and
satisfaction with health care after vaginal hysterectomy due to prolapse.
Methods:  We analyzed data from the Swedish National Register for Gynecological Surgery
(SNRGS) from January 1997 to August 2005. Women participating in the SNRGS were asked to
complete surveys at two and six months postoperatively. Of 941 women who underwent vaginal
hysterectomy for uterovaginal prolapse, 791 responded to questionnaires at two months and 682
at six months. Complications during surgery and hospital stay were investigated. The two-month
questionnaire investigated complications after discharge, and patients' satisfaction with their health
care. Sexual activity and urinary symptoms were reported and compared in preoperative and six-
month postoperative questionnaires.
Results: Almost 60% of women reported normal activity of daily life (ADL) within one week of
surgery, irrespective of their age. Severe complications occurred in 3% and were mainly intra-
abdominal bleeding and vaginal vault hematomas. Six months postoperative, sexual activity had
increased for 20% (p = 0.006) of women and urinary urgency was reduced for 50% (p = 0.001);
however, 14% (n = 76) of women developed urinary incontinence, 76% (n = 58) of whom reported
urinary stress incontinence. Patients were satisfied with the postoperative result in 93% of cases
and 94% recommended the surgery.
Conclusion:  Vaginal hysterectomy is a patient-evaluated efficient treatment for uterovaginal
prolapse with swift recovery and a low rate of complication. Sexual activity and symptoms of
urinary urgency were improved. However, 14% developed incontinence, mainly urinary stress
incontinence (11%). Therefore efforts to disclose latent stress incontinence should be undertaken
preoperatively.
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Background
In Sweden, at least 15% of women over the age of 40 years
suffer from vaginal prolapse or urinary incontinence [1-
3]. The incidence of pelvic organ prolapse increases with
age, and by age 80 a woman's lifetime risk of undergoing
a single operation for prolapse or urinary incontinence is
11%, with a 29% risk of reoperation [4]. As the popula-
tion ages, the need for medical care for uterine or vaginal
prolapse will probably increase.
Vaginal hysterectomy is one of several surgical procedures
for the correction of symptomatic prolapse. Reported ben-
efits of vaginal hysterectomy compared to abdominal hys-
terectomy in the U.S. include shorter duration of hospital
stay (WMD 1.0 day, 95% CI: 0.7 to 1.2 days), speedier
return to normal activities (WMD 9.5 days, 95% CI: 6.4 to
12.6 days), and fewer unspecified infections or febrile epi-
sodes (OR 0.42, 95% CI: 0.21 to 0.83) [5].
To the best of our knowledge no published study has
investigated the process of normal recovery in a routine
health care setting after vaginal hysterectomy due to pro-
lapse. The overall aim of this study was to describe the
course of events after vaginal hysterectomy as a treatment
for uterovaginal prolapse. The specific aims of the study
were to investigate operative and postoperative complica-
tions, perceived health, sexual activity, urinary symptoms,
and patient satisfaction with health care.
Methods
The Swedish National Register for Gynecological Surgery
In 1997, the Swedish National Register for Gynecological
Surgery was established and started to collect preopera-
tive, perioperative, and postoperative information on
women undergoing hysterectomy for non-malignant
pathology. The register has been used in other studies [6-
8] and covers approximately 60% of the Swedish female
population. In 1997, 11 of 56 departments of gynecology
and obstetrics in Sweden participated in the register; by
2005, 34 different gynecological units participated. Data
was collected through gynecologist forms and patient
questionnaires (Table 1). The patient questionnaires were
designed, constructed, and validated by the Department
of Educational Measurement, Umeå University, Sweden.
Three questionnaires (one preoperative, one two months
postoperative, and one six months postoperative), were
sent to the patients and returned to the gynecologist for
evaluation. The answers were later pooled into a central
database.
On the preoperative patient questionnaire (QP), patients
responded to detailed questions designed to classify, eval-
uate, and grade different diseases and symptoms, such as
"sensation of vaginal heaviness and/or protrusion/pro-
lapse" and urinary incontinence. Patients' self-reported
data concerning general health information were also col-
lected on the QP. The preoperative surgeon's form
included questions concerning physical and gynecologi-
cal examinations of the patient.
Table 1: Description of the sources of information in the Swedish National Register for Gynecological Surgery.
Questionnaire Collection time of questionnaire Questionnaire data content
Preoperative patient questionnaire (QP) At decision for surgery Sociodemographic data, health status, and 
medical assessment of patient's health data and 
symptoms reported by the patients
Preoperative form (Gynecologist) At decision for surgery History; physical and gynecological 
examinations
Operation form (Gynecologist) Directly after surgery Surgery data
Postoperative form (Gynecologist) After discharge Course of events during hospital stay
Two-month follow-up questionnaire answered 
by the patients (Q2)
Sent 6 weeks after surgery. Usually completed 
and registered approximately 8 weeks 
postoperative.
1st reminder is sent after 2 months + 3 weeks; 
2nd reminder is sent after 2 months + 6 weeks.
General and medical follow-up questions, 
wellbeing and surgery-related complications, 
recovery, ratings of satisfaction and 
improvement; gynecologist assesses patients' 
answers
Six-month follow-up questionnaire answered 
by the patients (Q6)
Sent 6 months after surgery. 1st reminder is 
sent after 6 months + 3 weeks; 2nd reminder is 
sent after 6 months + 6 weeks.
Identical questions as in QP for symptoms 
(urinary symptoms, dyspareunia) and sexual 
activity; gynecologist assesses patients' answersBMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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The two-month follow-up patient questionnaire (Q2)
contained general and medical follow-up questions con-
cerning patient-reported well-being, surgery-related com-
plications, recovery, and patient's ratings of satisfaction
and improvement. Questions about short-term complica-
tions following surgery were mainly included on the Q2
questionnaire.
In the two-month follow-up questionnaire (Q2), patients
were asked to report complications occurring after  the
hospital stay. Nevertheless, approximately 25% of major
complications occurring during  the hospital stay were
reported in the Q2. The Q2s were evaluated and assessed
by the responsible surgeons. The severity of postoperative
complications was evaluated by both the patient and the
gynecologist.
The Q2 questionnaires were sent to the patients by mail
six weeks after surgery and were usually completed and
registered approximately eight weeks postoperative. First
and second reminders, when necessary, were mailed out
approximately 11 and 14 weeks after surgery. (Table 1).
The six-month follow-up patient questionnaire (Q6)
included some questions identical to those on the QP
concerning sexual activity and urinary incontinence, as
well as questions about long-term complications, such as
dyspareunia, as opposed to the short-term complications
asked about on Q2.
The sample
We conducted a retrospective, cross-sectional, popula-
tion-based study using the SNRGS, which includes data
on all registered women who underwent vaginal hysterec-
tomy for uterovaginal prolapse from January 1997 to
August 2005. All levels of health care centers, from local
clinics to national university hospitals participated. The
inclusion criteria was vaginal prolapse with planned cor-
rection through vaginal hysterectomy (n = 941). Exclu-
sion criteria were surgical correction other than vaginal
hysterectomy (n = 71) and surgery less than two months
before closure of the database (n = 7). Women who
refused the postoperative questionnaires (n = 28) and
those who were assessed by their surgeons as unsuitable
for questionnaires due to difficulty with Swedish lan-
guage, mental disorder, or advanced age (n = 22) were
excluded from the follow-up study. The sample is pre-
sented in Figure 1. Variables used in the study were col-
lected from the SNRGS.
In total, 181 gynecologists were registered as responsible
surgeons for 4664 vaginal hysterectomies for all reasons;
941 of these operations were performed due to prolapse.
The range of registered number of operations per surgeon
was 1–49, and the median number was 3.
The Q2 was completed and returned by 791 patients; of
the 150 patients who did not complete the Q2, 64 had not
received the questionnaire.
Of 941 patients who had vaginal hysterectomy due to pro-
lapse, 827 received the Q2 questionnaire and 791
(95.5%) responded (Figure 1). Only 36 patients who
received the questionnaire did not respond. Patients were
routinely sent two reminders, but only four of the non-
responding patients received both reminders; the other 32
received no reminder (n = 20) or only one reminder (n =
12). Non-respondents' medical records (n = 36) were
retrieved after contact with the gynecological units of the
responsible hospitals. We found that among patients who
were not reminded at all, one subject was exposed to a
severe complication (intra-abdominal hematoma) during
hospital stay, which was subject to reoperation and was
reported in the postoperative form by the surgeon. Two
mild complications (urinary tract infection and vaginal
vault hematoma with spontaneous drainage) were noted
as well.
Of 941 patients who had surgery, 748 received the Q6
questionnaire and 682 responded (91%). Fifty women
were excluded from receiving both Q2 and Q6 (Figure 1).
Of 891 patients suitable for the Q6, 82 subjects were not
yet six months postoperative at the closure of the data-
base. There were 61 women to whom no questionnaire
was sent, due to failure in hospital routines.
Statistics
All statistical analyses were performed using SPSS 11.5.
Categorical variables were analyzed by Pearson's chi-
square or Fisher exact test and parametric data were ana-
lyzed by t-test. Holm's corrected Bonferroni method was
used to correct for multiple testing. A p-value less than
0.05 was considered significant. The study was approved
by the Ethics Committee University of Umeå, Sweden
(Dnr 08-076).
Results
Background characteristics of both respondents and non-
respondents to the two-month questionnaire are summa-
rized in Table 2. Using the Bonferroni adjustment for mul-
tiple tests we found no differences between the groups.
Operative and short-time post-operative results
Vaginal hysterectomy was the single surgical procedure
performed in 746 (79.3%) patients. Additional operative
procedures, such as a repair of a cystocele or a rectocele,
were identified in 154 cases (16.4%), of which eight cases
were surgery with Tension-free Vaginal Tape (TVT)
because of urinary incontinence. Information about con-
comitant surgery was missing in 41 subjects.BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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Mean estimated operation time was 76 minutes (95% CI:
74–78) and the mean blood loss volume was 128 ml
(95% CI: 119–136).
Conversion to laparotomy was performed in two cases,
one due to complication because of bleeding and the
other because of adhesions, narrow vagina, and immobile
uterus. Reoperation during hospital stay occurred in
about 1% of patients (Table 3).
The discharging gynecologist evaluated the operation and
postoperative hospital stay as without complications in
91% of cases, with minor complications in 7.5% of cases,
and with severe complication in 1%; missing information
constituted 0.5% (n = 22). Among 22 patients without
discharge data, 17 patients reported a recovery without
complications in the two-month follow-up question-
naire. For the remaining five patients, medical files were
retrieved and no complications were reported.
The prevalence of infections associated with the operative
procedures and occurring during hospital stay was esti-
mated at 2% for vaginal infections, 1.3% for urinary tract
infections (UTI), and 0.1% for vaginal infections and UTI;
96.6% of women did not develop an infection.
Most patients (95%) received preoperative antibiotics and
infection was reported in 1.3% (n = 11) of them. Infection
was not observed among the 47 women who did not
receive preoperative antibiotic prophylactic. This differ-
ence was not statistically significant (p = 0.403).
All major complications during the hospital stay that were
reported by the patients on the Q2 were also reported by
the surgeon on the postoperative form.
Postoperative results reported by respondents two months 
after surgery
Of 791 patients who completed the Q2, 17 patients
reported ensuing complications that required their re-
Flow diagrams of selection of subjects eligible for the study Figure 1
Flow diagrams of selection of subjects eligible for the study.BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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admission to the hospital. Three reported complications
that occurred during the hospital stay and 14 experienced
complications after discharge requiring readmission, of
which most were infections (Table 3).
There were 23 (2.9%) patients who required reoperation
during the hospital stay and readmission. There were no
statistically significant differences between these patients
and the rest of the study population regarding medica-
tion, preoperative functional state according to the Amer-
ican Society of Anesthesiologists Physical Status
Classification System (ASA), unexpected operation diffi-
culties, such as adhesions or presence of endometriosis, or
perioperative complications (Table 4). Women who had
complications were younger (p = 0.001) and had fewer
concurrent diseases (p = 0.007) than subjects with no
complications.
Of 23 complications that resulted in reoperation or
readmission, 19 (82.6%) complications occurred in sub-
jects who had solely vaginal hysterectomy and 4 (17.4%)
in subjects who had concomitant surgery. The difference
was not statistically significant (p = 0.93).
Patient-reported infections after discharge that required
antibiotics were vaginal infections in 3.9% (n = 31), lower
UTI in 5.6% (n = 44), and UTI and vaginal infection in
1.4% (n = 11). With only one exception, all cases with
Table 2: Test of difference for specified background variables for respondents and non-respondents.
Variable Respondents Non-respondents P-value
Preoperative forms distributed (%) 782 (98.7) 125 (83.3)
Mean age in yrs (SD; n) 63.6 (11; 782) 62.1 (11.9; 125)
Age group
< 50 years n (mean age yrs) 91 (44.1) 17 (42.4) 0.952
> 50 years n (mean age yrs) 700 (66.1) 133 (65.4)
Mean parity (SD; n) 2.47 (1.14; 741) 2.44 (1.27; 102) 0.799
Mean BMI (SD; n) 25.96 (3.6; 720) 26.3 (3.6; 102) 0.383
Mean weigh in kg (SD; n) 69.46 (10.75; 732) 70.18 (10.76; 104) 0.519
Mean height in cm (SD; n) 163.4 (6.0; 735) 163.1 (5.6; 103) 0.602
Patient's first rank of discomfort is prolapse
n (mean) 750 (1.24) 105 (1.26) 0.771
Hypertension
yes % (n) 32 (250) 29.6 (37) 0.597
don't know % (n) 68 (532) 70.4 (88)
Current disease other than gynecologic
Yes % (n) 65.9 (396) 69.3 (61) 0.525
no % (n) 34.1 (205) 30.7 (27)
Diabetes mellitus
yes % (n) 5.8 (35) 14.8 (13) 0.002
no % (n) 94.2 (566) 85.2 (75)
Asthma
Yes % (n) 4.2 (25) 10.2 (9) 0.014
no % (n) 95.8 (576) 89.8 (79)
Current use of estrogen
yes % (n) 34.3 (192) 28.4 (23) 0.294
no % (n) 65.7 (368) 71.6 (58)
Smoking
yes % (n) 12.5 (74) 18.4 (16) 0.127
no % (n) 87.5 (520) 81.6 (71)
Registration forms distributed* (%) 791 (100) 150 (100) 0.947
Mean uterine size estimated as corresponding gestational age (SD; n) 3.27 (1.66; 775) 3.28 (1.63; 143)
ASA I† % (n) 88.9 (518) 80 (68) 0.020
ASA II† or more % (n) 11.1 (65) 20 (17)
Number of operation forms available (%) 791 (100) 150 (100)
Mean duration time in minutes (SD; n) 76.61 (29.7; 778) 77.84 (30.1; 143) 0.652
Mean blood loss in ml (SD; n) 127.38 (131.3; 757) 128.86 (129.7; 138) 0.903
(Student's t- test for parametric data and Pearson's chi-square test for categorical data).
SD, Standard deviation; n, number of patients in each group.
* Registration forms were completed by the surgeon when decision for surgery was made.
† American Society of Anesthesiologists Physical Status Classification System.BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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infections received preoperative prophylactic antibiotics.
No signs of infection were reported by 89.1% of the
respondents.
Table 5 shows other complications reported by the
patients. Patients sought treatment for complications
from gynecological departments (8.8%) and general prac-
titioners (4.7%).
More than 90% of patients rated the length of the hospital
stay as adequate; the median hospital stay was 3 days,
with 44% of patients discharged within 2 days postopera-
tively. Patients' estimated time of return to normal activity
of daily life (ADL) showed no difference between age
groups (p = 0.093; Table 6).
In the two-month follow-up questionnaire, 32% reported
that a next visit was planned at discharge and was carried
out in 91% of those cases.
Of all women who answered the Q2, 76% reported that
they did not need any further contact with the gynecolog-
ical department, 8.5% wished contact with the surgeon,
11.9% asked for a return visit, and 3.5% did not respond
to the specific question.
From patients' postoperative questionnaires, surgeons
assessed no further intervention for 82%, a return visit for
9.7%, and telephone contact for 6.0%; information was
missing for 2.4%.
Evaluations of complications by surgeons compared with 
patients
Generally, patients and surgeons agreed about whether
there had been an adverse postoperative event (73%).
When opinions differed, patients tended to evaluate their
postoperative recovery as more complicated than their
surgeons did (15.7%), although the opposite evaluation
occurred in 1.7% (Table 7). Table 8 shows the discrepancy
in evaluation of severe complications between surgeons
and patients.
Both surgeons and patients unanimously considered
complications as mild in 10.5% (n = 83) of cases, and
51% of reported complications (n = 42) were treatable
infections such as UTI and bacterial vaginosis. The
remaining complications were relatively minor condi-
tions, such as fatigue, pain, urethritis, and constipation.
Table 3: Reoperations during hospital stay and complications resulting in readmission.
Reoperations during hospital stay n Treatment
Retroperitoneal or intra-abdominal bleeding 5 Reoperation
Bleeding from suture 2 Resuture
Vaginal vault abscess 1 Drainage and antibiotic
Urinary retention, due to combined TVT 1 Cutting TVT band
Complications resulting in readmission
Thrombosis 1 Low molecular heparin
Ileuses 1 Laparotomy, resection of small bowel
Vaginal vault abscess 8 Drainage and antibiotic or antibiotic only
Urinary retention, UTI 2 Catheter and revisit, antibiotics
Arthritis in knee joint, Allergic reaction 2 Consultant internal medicine
Table 4: Specified variables compared between patients with complications and patients with no complications.
Variable Uncomplicated Complicated P-value
Mean age in years 64 56 0.001
Mean BMI 26 24.5 0.034
Current disease beside gynecologic % 67 37 0.007
Current medication, % 66 50 0.132
ASA I % 85 85 0.982
No surgical difficulties, % 90 95 0.373
No perioperative complications, % 97 100 0.419
Mean operation time, min 77 65 0.003
Mean blood loss, ml 126 162 0.8
Student's t-test for parametric data and Pearson's chi-square test for categorical data.BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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Of the 115 patients who reported minor complications
while their surgeons reported no complications, 67% (n =
77) did not seek further medical care.
Ninety-seven per cent of the women reported that their
condition had been improved. The operation was recom-
mended by 94% of the women.
Results reported by respondents six months after surgery 
compared with preoperative reports
Only women who responded to both the preoperative
questionnaire (QP) and the Q6 were investigated.
Patients were asked to answer in both questionnaires the
specific question, "Did you have coitus in the last three
months?" Of 244 women who had coitus within three
months prior to surgery, 6.6% (n = 16) of them had not
resumed coitus within six months postoperative. Among
the 376 women who had not had coitus three months
prior to surgery, 17% (n = 64) had resumed coitus six
months postoperative. The number of women reporting
intercourse had increased by 20% from 244 to 292 cases
(p = 0.006). A total of 9% (n = 62) did not respond to the
specific question in the preoperative or the six-month
postoperative questionnaire.
Dyspareunia was evaluated by the patients with a visual
analogue scale (VAS) in the preoperative and six-month
postoperative questionnaires. The scale measured from 0
to 50 mm where 0 equalled complete absence of symp-
toms and 50 represented unbearable symptoms. The
mean value for dyspareunia according to the VAS was
reported as 0.90 mm preoperatively and 0.84 mm postop-
eratively. No statistical significant difference was found (p
= 0.072, 95% CI: 0.022–0.522).
Of 682 women who answered the Q6, 679 (99.5%)
answered questions regarding urinary symptoms, such as
urgency, urge incontinence, or urinary stress incontinence
in both the QP and the Q6. In the preoperative question-
naire 38.1% of the respondents (n = 259) reported urinary
problems; six months postoperatively this response
decreased to 30% (n = 204) (p = 0.002). Fourteen per cent
(76 of 545; Table 9) of women who were continent prior
to surgery became incontinent postoperatively, mainly
with urinary stress incontinence (n = 58). Conversely, of
134 women who reported urinary incontinence in the QP,
51.5% (n = 69) became continent postoperatively; 134
women were incontinent preoperative (19.7%) and 141
postoperative (20.8%; p = 0.685). Urgency was reduced
by 50.4% (p < 0.001; Table 9).
Sensation of vaginal heaviness or pressure was rated by
the patients with a visual analogue scale (VAS) in the QP
and the Q6. The scale measured from 0 to 50 mm where
0 equalled complete absence of symptoms and 50 repre-
sented unbearable symptoms. Of women who rated their
symptoms on a VAS scale as above 80% of the scales
length (n = 262) preoperatively, 73.3% expressed no
symptoms of heaviness or pressure on the six month fol-
low-up (p < 0.001, 95% CI: 2.32–2.63) and 81.3% (n =
620) had no symptoms regardless of previous grade of
heaviness. There were 62 women who did not respond the
specific question in the QP or the Q6.
Respondents reported that they were satisfied with the
result of the treatment in 93% (n = 629) of cases.
Discussion
The current study was a population-based study and hos-
pitals at every level from local, county-run to national,
university-affiliated, participated. It covers 65% of all
Departments of Gynecology in Sweden and approxi-
mately 60% of the Swedish female population. The main
finding of our study is that vaginal hysterectomy per-
formed for vaginal prolapse in routine clinical health care
setting results in short hospital stay, swift recovery, and a
low rate of complications. Furthermore, there is a high
grade of patient satisfaction and the results are compara-
ble to those of other studies of vaginal hysterectomy
regardless of indication [5,9].
Retrospective data may imply certain limitations. Weak-
nesses of the study include lack of information in the reg-
ister regarding the stage of the prolapse and the fact that
decisions to perform vaginal hysterectomy for prolapse
were made by individual surgeons. The register was first
Table 5: Other complications reported by the patients.
COMPLICATIONS REPORTING %
Conservatively treated intra-abdominal abscess* 0.8
Conservatively treated vaginal vault abscess* 4
Urinary retention 0.3
Fever > 38°C for two or more days* 4.3
Deep vein thrombosis 0.1
Fatigue 7.2
* Not receiving antibiotics.
Table 6: Patients' self-estimated time to recurrence to normal 
daily activity.
Age (years)
< 40 40–50 50–60 >60 Total
(n = 11) (n = 71) (n = 162) (n = 350) (n = 594)
Days %% % %
0–2 0 12.7 13.6 12 12.3
3–7 100 62 59.3 53.1 56.7
8–10 0 8.5 9.9 16 13.1
>11 0 16.9 17.3 18.9 17.8BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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developed to record hysterectomies for non-malignant
pathologies including prolapse. Therefore the frequency
of additional prolapse surgery (cystocele, rectocele) in the
registry is not representative of its frequency in the popu-
lation.
The aim of the study was not to assess the anatomical suc-
cess of the surgery, but rather to investigate patient-
reported perceptions postoperatively. The use of postop-
erative patient questionnaires has previously been vali-
dated and has been found to be highly accepted by
patients; furthermore, questionnaires provide more com-
plete and thorough collection of postoperative informa-
tion than follow-up visits [10].
The response rate in the patients' postoperative question-
naires (at two and six months) was very high. Non-
response in the postoperative questionnaire was mainly
related to flaws in participating hospitals' procedures for
sending the reminders. If the questionnaires (with two
reminders) were sent by surgeons responsible for the
patients, the response rate exceeded 95%. We did not find
any complications during hospital stay that were reported
by the patients but not registered by the surgeons. Thus,
the data from the SNRGS used in the current study was
without any greater bias or flaw.
A low rate of severe complications (3%) was found; these
were mainly intra-abdominal bleeding and vaginal vault
hematomas or infections. Surprisingly, there were no
recorded bladder injuries or perforations during surgery.
In a meta-analysis review article, the rate of complications
requiring reoperation after apical vaginal prolapse surgi-
cal repair was highest for vaginal mesh kit compared to
traditional vaginal surgeries and sacral colpopexy [11]. In
Sweden apical suspension to the sacrouterine ligament is
an integral part of vaginal hysterectomy when performed
for prolapse, but individual data on apical suspension was
not available for the present study.
In the present study because the frequency of complica-
tions did not differ between women who had vaginal hys-
terectomy only and those who had another concomitant
procedure (p = 0.93), concomitant procedures did not
seem to increase the risk for complications. However,
since the registry database does not record the type of api-
cal suspension used, we can not conclusively exclude
Table 7: Surgeons' and patients' evaluation of postoperative course of events.
Patients' evaluation of postoperative events
No complication Minor complication Severe complication Missing information Total answers





No complication 484 (61) 115 (14.5) 1 (0.13) 26 (3.3) 626 (79)
Minor complication 9 (1.14) 83 (10.5) 8 (1) 0 100 (12.6)
Severe complication 2 (0.25) 3 (0.38) 6 (0.76) 0 11 (1.4)
Missing information 30 (3.8) 14 (1.8) 6 (0.76) 4 (0.5) 54 (6.8)
Total answers 525 (66.3) 215 (27) 21 (2.65) 30 (3.8) 791 (100)
Table 8: Discrepancy in the evaluations of severe complications between surgeons and patients.
Surgeon Patient Complications reported at two-month follow up
Severe None Perioperative paresis of the peroneal nerve*
Severe None Intra-abdominal bleeding*
Severe Mild Two cases of intra-abdominal bleeding* and drainage of vaginal abscess
Severe Mild Thrombosis treated with low molecular heparin
None Severe Upper UTI 6 weeks postoperative
Mild Severe Urinary incontinence that might have increased after operation
Mild Severe Vaginal vault abscess 3 weeks postoperative, treated with antibiotics and drainage
Mild Severe Dyspareunia because of narrow vagina
Mild Severe Upper UTI two months postoperative
Mild Severe Vaginal vault infections, 4 cases, 1–3 weeks postoperative, treated with antibiotics
*Complication occurred during hospital stay.BMC Women's Health 2009, 9:9 http://www.biomedcentral.com/1472-6874/9/9
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additional procedures as possible additional risk factors
for complications.
UTI and vaginal infections dominated (50%) mild com-
plications. The main difference between patients with and
without complications was age and the majority of the
complications were attributed to infections. Likewise,
younger patients have an increased risk for postoperative
infection [12].
The patients reported more complications, and of greater
severity, in the postoperative course than the surgeons
did. Disagreements mostly arose when patients reported
complications and surgeons did not or were unaware
[13]. We believe patients evaluated the severity of compli-
cations based on their experience of discomfort, while sur-
geons evaluated complications based on the level of
medical risk. Patients and surgeons had different frames
of reference for risk assessment.
The finding in patients' self-assessment of recovery to
ordinary activity of daily life was not highly affected by
age or general health, presumably because the patients
compared their postoperative activity with their normal
preoperative functioning.
The number of women who were sexually inactive prior to
surgery and resumed sexual activity after surgery was four
times higher than women who were sexually active prior
to surgery and had not resumed sexual activity by six
months postoperatively. Overall we found that vaginal
hysterectomy for prolapse had a positive effect on sexual
activity.
Prolapse is often accompanied by urinary symptoms
[14,15]. An earlier study has shown that urinary fre-
quency, urgency, and urge incontinence disappeared in
60%, 70%, and 82% of women respectively one year after
the repair of anterior vaginal wall prolapse [16]. In this
study, while symptoms of urgency and urge incontinence
were reduced by half, the proportion of women with uri-
nary stress incontinence (USI) doubled postoperatively.
Not uncommonly, pelvic organ prolapse may lead to
latent USI [15]. In the current study almost 11% (58/545)
of respondents who were continent prior to surgery
reported urinary stress incontinence six months postoper-
atively. Performing urodynamic investigations in patients
undergoing prolapse surgery [17] and ring pessary reduc-
tion of severe prolapse during urodynamics [15] has been
shown valuable for diagnoses of USI or occult USI. Efforts
to disclose latent stress urinary incontinence should be
undertaken preoperatively.
Further studies are needed, particularly relating to long-
term results after prolapse surgery.
Conclusion
Vaginal hysterectomy is a patient-evaluated efficient treat-
ment for uterovaginal prolapse with a swift recovery and
a low rate of complications. Sexual activity and symptoms
of urinary urgency were improved. However, 11% of the
respondents developed urinary stress incontinence.
Therefore efforts to disclose latent stress incontinence
should be undertaken preoperatively.
Abbreviations
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Table 9: Urinary symptoms reported by patients, preoperative and six months postoperative.
6 months postoperative
Preoperative No reported symptoms Urgency Urge incontinence Stress incontinence Total
No reported symptoms
n (%)
336 (49.5)* 31 (4.6)† 11 (1.6)‡ 42 (6.2)§ 420 (61.8)*
Urgency
n (%)
78 (11.5) 24 (3.5) 7 (1)‡ 16 (2.4)§ 125 (18.4)†
Urge incontinence
n (%)
40 (5.9)‡ 6 (0.88) 15 (2.2) 23 (3.4) 84 (12.4)‡
Stress incontinence
n (%)
21 (3)§ 2 (0.3) 4 (0.4) 23 (3.4) 50 (7.4)§
Total, n (%) 475 (70) 63 (9.3)† 37 (5.4)‡ 104 (15.3)§ 679 (100)
*Of respondents without preoperative urinary symptoms, one fifth reported urinary symptoms postoperatively.
†Urgency is reduced in about half of those reporting it preoperatively, but half of the respondents with postoperative urgency had no preoperative 
symptoms.
‡Urge incontinence is reduced by about 60%, however almost half of women with postoperative urge incontinence were continent preoperatively.
§Number of women with postoperative stress incontinence doubled compared to number preoperative.Publish with BioMed Central    and   every 
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